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Abstract
Studies of diseases associated with pathological irreversible aggregation of proteins
have become of special relevance and attracted the attention of researchers through‐
out the world because of the appearance of a new conceptual model based on the
capacity of some proteins to self-assemble by the prion mechanism. Along with direct
prion diseases, such as bovine rabies and Creutzfeldt-Jakob disease in humans, a great
number of neurodegenerative disorders associated with the formation of aggregates
through the prion mechanism are revealed. These disorders include Alzheimer’s and
Parkinson’s diseases, amyotrophic lateral sclerosis, Huntington disease, and mucovis‐
cidosis, some types of diabetes and hereditary cataracts. The listed diseases are caused
by transition of a “healthy” protein or peptide molecule from the native conformation
to a  very stable  “pathological”  form. In this  case,  molecules  in  the “pathological”
conformation  aggregate  specifically,  forming  amyloid  fibrils  that  can  multiply
infinitely. An important result of studying the molecular mechanisms of prion diseases
and different proteinopathies, associated with the formation of pathological aggrega‐
tions by the prion mechanism, is the discovery of protein chain regions responsible for
their aggregation. The ability to regulate aggregation (fibrillation) of proteins can be the
focal tool for the drug development. Herein by the example of 29 RNA-binding proteins
with prion-like domains, we demonstrate what role the amino acid repeats in prion-
like domains can play. For these proteins, quite different repeats are revealed in the
disordered  part  of  the  protein  chain  predicted  with  bioinformatics  methods.  Ten
proteins of the 29 RNA-binding proteins are involved in the development of some
diseases. The prion-like domains of FUS, TAF15, and EWS are critical for the aggrega‐
tion of proteins associated with human neurodegenerative diseases. Proteins of this
family are involved not only in neurodegenerative diseases, such as amyotrophic lateral
sclerosis (ALS), Huntington disease, spinocerebral ataxy, and dentatorubral pallido‐
luysian atrophy, but also in the formation of human mixoid liposarcoma. It can be
suggested that the presence of a great number of repeats in prion-like domains of RNA-
binding  proteins  can  accelerate  the  formation  of  a  dynamic  beta-structure  and
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pathological  aggregates,  which are crucibles of  amyotrophic lateral  sclerosis (ALS)
pathogenesis.
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1. Introduction
Misfolded proteins  leading to  formation of  protein  aggregations  are  a  reason for  many
diseases. There is no definite answer to the question what causes death of cells where such
aggregations have been found: is this the cell defence mechanism or plain death? In a normal
state, cells that accumulate such aggregations are usually programmed to death or apopto‐
sis.  Cell  fragments  subjected  to  apoptosis  are  removed  by  phagocytic  cells.  However,
aggregations like amyloid fibrils are known to be resistant to the action of different proteas‐
es [1] that can impede the effective termination of efferocytosis and, as a result, accumulate in
tissues. In any case, there is undoubtedly close association of the formation of aggregations
and the development of many fatal diseases. There are several models describing the process
of fibril formation. For example, in order to begin aggregation, proteins should be prelimi‐
narily unfolded or partially folded [2]. As known, the generation of fibrils is facilitated by
denaturing conditions. At the same time, aggregation of peptides and proteins involved in
pathogenesis of such types of amyloidosis as type II diabetes, Alzheimer’s, and Parkinson’s
diseases does not necessitate preliminary unfolding of a protein molecule. But these data
sooner support the general rule, because under physiological conditions most of these proteins
have no definite structure, i.e., are natively unstructured [3]. However, most natively unfolded
protein in  vivo does  not  aggregate  [4].  Moreover,  unstructured proteins  are  resistant  to
denaturing conditions, i.e., to the factors bringing about stress, and, in the first place, high
temperatures [5]. It was demonstrated that the absence of structure does not correlate with the
aggregation capacity [6]. Therefore to avoid spontaneous self-assembly of a protein mole‐
cule, the evolutionary selection has led to an increased content of such amino acids as proline
and glycine that inhibit protein aggregation [7] and to an increased content of charged amino
acids [8]. On the contrary, due to a large number of amyloidogenic regions, globular pro‐
teins have developed capacity to avoid aggregation because of rapid folding into a globular
structure. This shows that protein unfolding is necessary but not sufficient for activation of
amyloid fibrils. It is most likely that there should be special motifs of amino acid sequences
exposed to the solvent, which are more liable to aggregation than other regions of the amino
acid sequences. Experimental data corroborate the hypothesis that there are small regions of
a protein molecule responsible to the amyloidogenic behavior [9–11].
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2. Role of repeats in protein aggregation
It has remained unclear what the mechanism of the earliest stage of initiation of the pathologic
irreversible aggregation of proteins is and how this process is triggered in healthy organisms.
It is supposed that the key role in the development of systematic amyloidosis belongs to the
so-called primes or factors accelerating pathologic aggregation. Such primes can be infectious
agents as well protein molecule regions containing motifs of low complexity, especially when
these motifs are recurrent. It was shown that the more frequently the repeats occur in a protein
sequence, the less structured the protein is. Generally, most homo-repeats are not structured
[12–15]. Nevertheless, this is not characteristic of fibrillar proteins [16], the capacity of which
to aggregation depends strongly on the amino acid sequence of the protein [17–19]. For
example, if the identity of the amino acid sequence of immunoglobulin domains is lower than
30–40%, the proteins lose their capacity to co-aggregation [18]. Using the bioinformatics
analysis, it has been established that in a large number of multidomain proteins the identity
of amino acid sequences of their domains is below 40%. It suggests a conclusion that in this
way the domains avoid mutual aggregation.
The existence of repeats in proteins and the clarification of their special roles are in the focus
of attention of researchers. The role of different repeats is studied actively, including repeats
such as PGMG (GPGM) and PNN upon biomineralization of PM27 proteins [20], NPNA
(NANP) repeats in circumsporozoite protein of Plasmodium falciparum, YSPTSPS repeats in
RNA-polymerase II, PHGGGWGQ repeats in prion protein, YGHGGG(N) and YNHGGG(G)
repeats in plant proteins rich in glycine, PGQGQQ, PGQGQQGQQ, and GYYPTSOQQ repeats
in wheat gluten, and FGGMGGGKGG repeat in bivalves (Aequipecten abductin). As a rule,
conformational loops formed by these repeats are stabilized upon interaction with different
cations; they are characterized by noncovalent interactions, particularly, interactions of
aromatic groups. It was demonstrated that many tandem repeats add plasticity and mobility
to the protein [21]. A leader on the occurrence of repeats in proteins is P. falciparum where 35%
proteins of 5300 have repeats. Moreover, P. falciparum contains 24% proteins with prion-like
domains rich in asparagine, whereas flies have only 3.4% of such proteins [22]. The occurrence
frequency of asparagine repeats in our HRaP database (http://bioinfo.protres.ru/hrap/) [14]
shows that P. falciparum is the leader. Of interest is the fact that one of the functions of these
homorepeats is connected with the parasitic life [14]. For example, the sequence of the protein
from P. falciparum (ID Q8IKW2_PLAF7 1304 aa 493.P_falciparum) has asparagine homorepeats
of different lengths, the maximal length reaching 41 amino acids. The basic functions of this
protein are associated with processes such as deacylation of proteins and “silence” of chro‐
matin [14].
3. Cell stress and generation of stress granules
Cell stress can also be an important factor of initiation of aggregation even though each cell
has developed an intricate defence system, because it is subjected to destructive stress action
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at regular intervals. A striking example of waiting till stress is over in the formation of stress
granules (SG), when the nontranslated mRNA and RNA-binding proteins are assembled in
ribonucleoprotein (RNP) complexes in order to terminate protein synthesis and thereby
maintain cell energy. In this case, only those proteins that are synthesized are required for cell
survival [23]. This means that after termination of the stress action, SGs disintegrate rapidly
and the “released” mRNA resumes its functioning. However, if due to some reasons, the
residence time of such proteins in SGs increases or their concentration in SGs exceeds the norm,
disintegration of SGs can be impeded, creating favorable conditions for generation of the
“center of aggregation initiation” that may induce transition to irreversible pathologic protein
aggregation [24]. A detailed analysis of the mechanism of assembly and disassembly of SGs
can provide a new insight into the development of diseases associated with this process and
suggest novel therapeutic approaches. Since the main function of SGs is protection of cells
from stress, many investigations are conducted to reveal factors shifting the balance of
reversible aggregation towards pathology after stress termination (Figure 1).
Figure 1. Schematic representation of different conformational states of self-assembly and disintegration of prion-like
domains and a possible transition to irreversible pathologic aggregation. Modified and adapted from Li et al. [25].
It is assumed that due to self-assembly, RNA-binding proteins can facilitate formation of SGs
using prion-like domains [26–28]. At any rate, it has been established that namely the struc‐
tured part of RNA-binding proteins is responsible for the formation of hydrogel and binding
to it [29]. Thus, protein FUS maintained its capacity to form gel even without the removal of
the C-terminal region that corresponds to the RNA-binding domain and lost this capacity upon
removal of the N-terminal unstructured region corresponding to the prion-like domain. The
capacity to bind to hydrogel has been established for proteins such as hnRNPA2, RBM3 RNA-
binding proteins, hnRNPA1, TIA1, CPEB2, FMRP, CIRBP, TDP43, and yeast Sup35. The
formation of hydrogel was also demonstrated for the hnRNPA2 protein, and it was shown that
proteins are retained to a different degree by hydrogel formed of different proteins [29].
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4. The role of RNA-binding proteins with prion-like domains in diseases
Studies of the human genome have allowed isolating a set of RNA-binding proteins with a
canonical RNA-binding motif. For example, prion-like domains were predicted for 29 of the
210 RNA-binding proteins for human diseases [30]. Ten of these 29 proteins are associated
with neurodegenerative diseases, i.e., proteinopathies [31]. In this chapter, we focus our
attention on isolation of repeats in well-studied proteins of the FET/TET family that are
included in this group of 10. To elucidate the mechanism of pathologic aggregation of proteins,
we have set ourselves the task to determine what repeats of amino acid residues in RNA-
binding proteins can be responsible for reversible and irreversible aggregation.
The prion-like domains predicted for TDP-43 and FUS overlap with the region containing a
large number of glycine residues. The prion-like domains are critical for aggregation of these
proteins associated with human neurodegenerative diseases [32]. It was found that protein
TAF15 is also involved in the development of disorder such as amyotrophic lateral sclerosis
(ALS) or Lou Gering’s disease [33]. At first, this protein was discovered using a bioinformatics
analysis as a possible candidate and later it was revealed in ALS patients. It turned out that
this protein has very similar properties to those of TDP-43 and FUS proteins involved in this
disease. The only difference is that mutations of the protein associated with this disease are
capable of higher aggregation in vitro than the wild-type protein, exert a stronger effect on the
lifetime, and lead to incorrect localization of proteins in the spinal cord of mammals [33].
Among 29 candidates of RNA-binding proteins with predicted prion-like domains, the first
and second places belong to FUS and TAF15, whereas TDP-43 is the 10th in this list [34].
Probably, it is expedient to pay attention to the first 10 proteins because the third place belongs
to protein EWS [35]. They should also be detected in ALS patients.
5. Members of the FET family: FUS, EWS, TAF15
Members of the FET family are very similar RNA-binding proteins containing the following
main domains in their structure: a SYGQ-rich N-terminal prion-like domain enriched with
uncharged polar amino acids (asparagine, glutamine, serine, and tyrosine) and glycine [36],
an RNA-binding motif (RNA-recognition motif, RRM), a “zinc finger” motif, and several RGG
domains rich in glycine [37–39]. Three proteins (FUS, EWS, and TAF15) also have a nuclear
location signal (NLS) that is recognized by the nuclear receptor transportin and is responsible
for protein transport from the cytoplasm into the nucleus and back [27, 40–43]. Genes of the
FET family are expressed practically everywhere. Proteins of this family are involved in
regulation of different stages of gene expression, including transcription, pre-mRNA splicing,
mRNA transport, and also take part in DNA repair [44–46]. The family name stems from three
capital letters of its three members: proteins FUS/TLS (fused in sarcoma or translocated in
liposarcoma), EWS (Ewing’s sarcoma), and TAF15 (TATA-binding protein-associated factor
2N) [47]. These RNA-binding proteins participate in many cell processes, including transcrip‐
tion, pre-mRNA splicing, DNA repair, and mRNA transport in neurons [44–46]. As a rule,
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under stress conditions such RNA-binding proteins shift from the nucleus into the cytoplasm
and take part in the formation of SGs, after which they return to the nucleus. This cycle is
multiply repeated during the cell lifetime, and it is not excluded that under such conditions
errors may occur in its functioning. The mechanism of activity of FET proteins, their cellular
localization, and determination of domains involved in different processes are to be clarified.
Prion-like domains of these proteins associated with human neurodegenerative diseases are
critical for their aggregation [32]. Proteins of this family are involved not only in neurodege‐
nerative diseases, such as ALS [33], Huntington’s disease, spinocerebellar ataxia, and denta‐
torubral cerebellar atrophy [48], but also in the development of human mixoid liposarcoma
[49–51].
5.1. FUS: Its functions, structural peculiarities of a prion-like domain, mutations
associated with diseases
A member of the FET family is the RNA-binding protein FUS, for which a number of mutations
associated with ALS have been revealed [27, 40–43, 52]. Under normal conditions, this protein
is localized mostly in the nucleus, whereas under pathologic conditions its aggregations are
accumulated in the cytoplasm. It was demonstrated on several cell models that FUS delocalized
in the cytoplasm was accumulated in SGs. This permitted a conclusion that a high concentra‐
tion of the protein facilitates generation of protein aggregations under FUS pathology [53, 54].
Nonetheless an exact mechanism by which this transformation occurs remains unclear. It is
not excluded that prion-like domains affect aggregation-like prions or fibril formation
analogous to amyloidogenesis. It is also possible that FUS, accumulated in large amounts,
aggregates in the cytoplasm independently of its capacity to sequestration in SGs. The protein
accumulation can also facilitate dysfunction of the protein intracellular degradation systems
that frequently occurs parallel to neurodegenerative disorders [55]. It should be noted that
under sporadic ALS diseases, the control of splicing of a large amount of genes is violated [56].
The FUS protein also regulates alternative splicing, as a rule binding to transcripts containing
large introns. Therefore, accumulation of FUS in the cytoplasm can result in the loss of its
function in the nucleus and consequently violation of the alternative splicing of a number of
genes, e.g., coding proteins associated with the growth and development of axons and the cell
cytoskeleton [57]. This version is in agreement with the results obtained on a drosophila model,
when an increased FUS concentration in the cell was extremely toxic for organisms that can
also cause dysfunction during splicing. In addition, enhanced expression of the gaz gene of
the fus ortholog caused death at the pupal stage [58].
In transgenic Caenorhabditis elegans worms, in which serine 57 was removed in protein FUS,
paralysis occurred much earlier when compared to transgenic species with a full-sized FUS
protein [59]. Therewith, the sequence of the FUS protein itself corresponded to that of the FUS
protein from the human proteome. This mutation (removal of serine 57) is associated with the
sporadic form of ALS [60]. It has been shown that for aggregation and toxicity of yeasts a prion-
like (1–239) and an RGG2 (374–422) domains are required, though FUS (1–359) is sufficient for
aggregation in models of neuroblastoma cells [54]. Domain RGG3 does not affect aggregation,
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and mutations in (502–526) lead only to the protein accumulation in the cytoplasm and its
insertion in SGs. In yeasts, FUS was accumulated only in the cytoplasm [61]. Some components
of SGs, such as translation initiation factors and poly-A-binding proteins, suppress toxicity of
FUS aggregations. It is important that many proteins associated with RNA metabolism can
affect the toxicity of FUS aggregations.
To verify the hypothesis that dislocation of FUS from the nucleus into the cytoplasm leads to
the loss of its function in the nucleus, Murakami et al. created transgenic animals with double
gene expression. One of these genes (fus) having the N-terminus, labeled with red fluorescent
protein RFP, could not move into the cytoplasm under the action of stress, and the other gene
(mutant GFP-fus-P525L) was uniformly distributed both over the nucleus and the cytoplasm.
After heat shock, most of GFP-FUS-P525L moved into the SGs, whereas GFP-RUS remained
in the cytoplasm. Therewith, the damaging effect was the same as in the experiment with
expression of only GFP-fus-P525L. Therefore, the authors concluded that accumulation and
aggregation of FUS in the cytoplasm are more neurotoxic than that when FUS lost its function
in the nucleus [62].
In any case, formation of such aggregations is the reason for apoptosis, i.e., the process of
programmed cell death. Apoptosis is characterized by retaining fragmentation of intracellular
components with retention of the integrity of the plasmatic membrane that facilitates fast
phagocytosis.
5.2. Role of FET proteins in the formation of stress granules
To understand the mechanism of assembly and disassembly of SGs, it is necessary to know
what regions of the chain of RNA-binding proteins can perform the function of a prime and
what the role of unstructured regions of simple complexity is. It is worth noting that in many
respects protein FUS is a perfect model for studying processes involved in the formation of
protein aggregations by the prion mechanism. To search for and reveal properties of prion-
like domains, we have chosen three proteins from the FET/TET family of 29 RNA-binding
proteins of the human proteome, the structures of which included prion-like domains [31].
The prediction was made using the algorithm developed by Alberti et al. [63], which is based
on the choice of protein regions of 60 amino acid residues, similar in the amino acid content
to the prion domains of yeast proteins, such as Sup35, Ure2p, and Rnq1p [64]. As a rule, these
regions are rich in hydrophilic amino acid residues such as glutamine, asparagine, and
tyrosine. In the range of proteins used in the prediction of prion-like domains, the first and
second places belonged to FUS and TAF15 among 29 candidates of RNA-binding proteins,
and the third was protein EWS [35].
The experiments, devoted to disclosing the capacity of protein FUS to aggregate, demonstrated
that upon deletion of the most part of the predicted prion-like domain the protein lost its
capacity to self-assemble; however, the formed aggregations did not reveal toxicity (Figure 2)
[67]. Some components of SGs, such as translation initiation factors and poly-A-binding
proteins, suppress toxicity of FUS aggregation [67]. It is important that proteins associated
with RNA metabolism can affect the toxicity of FUS aggregations. Prion-like (1–239) and RGG2
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(374–422) domains are also required for aggregation and toxicity of yeasts, although FUS (1–
359) is sufficient for simulations on the neuroblastoma cell culture [68]. Domain RGG3 does
not affect aggregation, and mutations at (502–526) result only in accumulation of the protein
in the cytoplasm and its insertion in SGs [24, 69]. It should be mentioned that in contrast to
mammalian cells, in yeast cells protein FUS is accumulated largely in the cytoplasm [61]. This
may be connected with the fact that NLS FUS is not recognized by nuclear receptors of yeasts
[65]. In mammalian cells, protein FUS is accumulated in the cytoplasm only when it has
mutations distorting the reverse transport into the nucleus [69].
Figure 2. Effect of different constructions of FUS on aggregation and toxicity in yeasts and aggregation and localization
in SGs in cell culture of the SH-SY5Y neuroblastoma [65, 66].
The N-terminal domain of FUS has 27 different variants of GYG, GYS, SYG, and SYS triplets
(that can be designated as [G/S]Y[G/S] repeats) [70]. Four mutants were obtained with a
different number of substituted tyrosine residues for serine ones to demonstrate that namely
tyrosine residues are responsible for the formation of hydrogel. There were 5, 9, 15 substitu‐
tions and all 27. Neither of the mutants could form hydrogel, however, all of them could equally
well bind to it. Mutants with substituted residues 5 and 9 could bind to hydrogel, but the
remaining mutants could not [70].
5.3. Disordered regions in proteins of the FET family and search for partners for
interactions with these proteins
For all three proteins, the IsUnstruct program [15] predicts the presence of unstructured
domains, as a rule, at the N and C termini of the polypeptide chain. Unstructured proteins
often play the role of hubs, i.e., have a capacity to concentrate a large number of partners
around them (it is accepted that when there are more than five partners, it is a hub) [71]. To
what extent is this role validated? To answer this question, it is necessary to determine the
presence of functional sites in the protein considered. The search for the number of partners
in the STRING database revealed that it exceeds 5 [72] (see Figure 3). Usually upon binding to
a partner, natively unfolded proteins can acquire a structure that imparts a certain function to
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them. In other words, the conformation of unstructured proteins is “dictated” by the interac‐
tion partners. This explains their capacity to perform different functions both in the cell and
in the extracellular space. For example, the analyzed RNA-binding proteins have regions with
large amounts of glycine in addition to large amounts of asparagine, glutamine, and tyrosine,
which also facilitates their unfolded state and performance of various functions in the cell
because these proteins are involved in the formation of RNP complexes, control of DNA
transcription, pre-mRNA splicing, protein posttranslational modification, and many other
vital functions [73]. According to the STRING database (version 10), the number of partners
is 44 for TAF15, 132 for EWS (Figure 3), and 218 for FUS.
Figure 3. The list of partners for EWS has been obtained from the STRING database using the information from the
data bases, data about homologies, possible co-expression, experimental confirmation about interactions, etc. The
boundary condition for entry in the list of partners is probability of interactions equal to 0.4. Transparency of edges
connecting vertices in the graph designates probability of interaction. The more transparent of edge, the less probabili‐
ty of interaction.
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These proteins contain many motifs of simple complexity. As shown, the portion of proteins,
included in periodic fragments or homorepeats, is an order of magnitude lower in eukaryotic
proteomes than in bacterial ones [74, 75]. The proteins with periodic fragments are extremely
nonuniformly distributed both over the kingdoms and over organisms within each kingdom
[74, 75]. It is worth underlining that these repeated motifs can be located in the region not
predicted as prion-like. It is known that protein Ure2 has regions in the carboxy-terminal
domain affecting the capacity of the amino-terminal domain to become prion-like [76]. The
available data for FUS allow us to conclude that the presence of both a prion-like domain and
a C-terminal region corresponding to the RGG2 region (see Figure 2) is important for patho‐
logic aggregation. It is most likely that the RNA-binding domain also contributes to the
pathologic aggregation. The RNA-binding motif (RRM) in proteins RUS and TAF15 is highly
identical and is retained from species to species. On the contrary, the RNA-binding motif
(RRM) in protein EWS differs remarkably from other members of the family and does not
preserve 100% identity in different species. For example, for FET proteins, the following
amyloidogenic regions, revealed using program FoldAmyloid [77], can be indicated in the
RNA-binding domain (RRM): AIYVQ/ADFFK/MIHIYL/VEWFD for EWS; TIFVQ/INLYT/
IDWFD for TAF15; and TIFVQ/INLYT/IDWFD for FUS.
The prediction of unstructured regions in proteins of the FET/TET family using program
IsUnstruct allowed us to isolate two unstructured domains at the N and C termini and one
structured region, corresponding to the RNA-binding domain. Figure 4 shows probability
profiles for amino acid residues of the FET/TET proteins, which make it possible to determine
whether they are structured or unstructured. Motifs in the amino acid sequence are shown by
different colors. These proteins are characterized by the presence of a large number of
homorepeats when one amino acid is recurrent many times. Generally, the longer are the
repeats, the higher is the probability that the aggregated protein containing and it is associated
with the development of a disease. For example, protein FUS is characterized by five unstruc‐
tured patterns from the pattern library obtained by us from the Protein Data Bank: GSHM,
GGGGSGG, GGGGG, GGSGGGGSGGG, and RGGGGSG. The occurrence of these patterns in
the given protein in different organisms (human, monkey, pig, mouse, quicken and fish) can
be found in our HRaP database, containing data on the occurrence of unstructured patterns
and homorepeats in 122 proteomes [14]. For protein TAF15, the glycine-rich recurrent motif is
well isolated at the C-terminus: DRGGGYGG/DRSSGGGYSG/DRGSRGGYGG, which is
characteristic of many animals and fish [78]. We isolated 22 repeats, and the Uniprot program
finds 21 repeats at the C terminus: GRGGRGG/DRGGYGG (Figure 4). As concerns EWS, we
can observe 14 repeats as SYSQAPS in the prion-like domain (the N-terminal part) and 6
repeats (DRGRGGPGG) in the C-terminal part (Figure 4). It should be noted that 15 imperfect
repeated motifs (QPGQGYSQQSS) are positioned in a prion-like region (the N-terminal part)
and four repeats (DDRRGGRGGY) in the C-terminal one for FUS (Figure 4).
As known, protein regions enriched in glycine residues cannot have a rigid spatial structure;
therefore, the main function characterizing this protein region is determined by a number of
adjacent amino acid residues. It should be noted that in the mentioned proteins with high toxic
aggregation, the glycine repeats adjoin arginine, serine, and tyrosine. Domains rich in glycine
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and arginine (RGG) are known to be responsible for the interaction of proteins with each other
and with RNA. As a rule, these interactions are controlled by methylation of arginine [79],
whereas phosphorylation of serine residues affects the direct mutual interaction of prion-like
domains [45, 80]. Of interest is the fact that deletion of serine (S57), the mutation associated
with sporadic form of ALS [81], induced paralysis in transgenic C. elegans species, that took
place much faster than in transgenic species with a full-sized human FUS [82]. These data make
Figure 4. Probability profiles of amino acid residues in proteins of the FET/TET family (A for FUS, B for TAF15, and C
for EWS) according to which it is possible to predict possible formation of the structure or its absence by the IsUnstruct
program [15].
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it possible to suggest that phosphorylation and dephosphorylation of serine residues are
critical not only for self-assembly of prion domains but also for disassembly by aggregation
when required, e.g., termination of stress action on the cell. It was assumed that the presence
of tyrosine residues facilitates the formation of hydrogel. In this connection, it should be
mentioned that in spite of high similarity of these proteins, relative to other members of the
family, the cytoplasmic aggregation of FUS is more toxic that correlates with longer glycine
repeats in the amino acid sequence of FUS [33].
5.4. Zinc-finger motif in proteins of the FET family
All proteins of the FET/TET family are characterized by the presence of a zinc-finger motif.
The exclusion is the EWS protein in chickens, because here the zinc-finger motif has not been
determined [78]. As known, a classic zinc-finger motif forms a loop, where two cysteine
residues and two histidine residues bind zinc ions. The main function of a classic zinc-finger
motif is the binding of DNA, which corresponds to its structure consisting of two to three beta-
sheets in the N-terminal region of the protein and one alpha-helix in its C-terminal region. As
for the FET/TET family of proteins, the amino acid sequence of the zinc-finger motif in them
differs significantly from the classic consensus motif (Cys-X2–4-Cys-X3-Phe-X5-Leu-X2-His-X3-
His) [83]. It should be noticed here that the amino acid sequence of this motif in proteins FUS
and EWS is highly similar, which is preserved in all organisms studied by us. Our plots on the
prediction of the structure demonstrated quite well the correspondence of this motif and the
predicted structure (Figure 4: proteins FUS and EWS, second peak from the bottom, blue). On
the contrary, in TAF15, this motif differs somewhat not only from FUS and EWS but also in
the organisms studied by us; according to our prediction, it forms no structure (Figure 4). It is
important that in proteins of the FET/TET family the zinc-finger motif occurs only once,
contrary to the classic variant when it occurs as tandem repeats. As a rule, if the zinc-finger
motif occurs once and its sequence differs considerably from the canonical one, the functions
of this motif can differ remarkably from the classic motif. For example, it can both be bound
to RNA and have no relation to the binding of nucleic acids [83]. The removal of this motif
together with the terminal part of the FUS molecule did not affect the protein ability to
aggregate and have toxicity either in yeasts or in the cell culture of the SH-SY5Y neuroblastoma
[67]. Additional studies should be conducted to reveal the functions of the zinc-finger motif
in proteins of the FET/TET family.
6. Conclusion: Repeats are a general characteristics of prion-like domains
In this study, we have analyzed RNA-binding proteins with prion-like domains, such as
TAF15, FUS, and EWS. Using the FoldAmyloid program [77], we revealed the existence of
amyloidogenic regions in the RRM domain in all three proteins of the FET family. This allows
us to suggest that when the binding to RNA is violated, the proteins can aggregate spontane‐
ously forming amyloid fibrils. In this case, protein FUS can aggregate both upon the removal
of RRM and at point mutations in this domain [65, 66]. Further studies should be conducted
to clarify whether aggregation of protein FUS in the presence of RRM does not lead to the
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formation of irreversible pathologic aggregations and functions only by the mechanism of
assembly and possible disassembly under favorable conditions analogous to the functioning
of SGs. We have also found that in all members of the FET/TET family the zinc-finger motif
does not correspond to the classical one because it concerns both the location of tandem repeats
and the amino acid sequence. Moreover, according to our prediction, in the FUS and TAF15
proteins, it does not even form any structure. Based on this, we can propose that in proteins
of the FET/TET family the zinc-finger motif is not responsible for the DNA binding, but
performs other functions determination of which requires further investigations.
We have also predicted unstructured regions corresponding both to prion-like domains and
to additional regions, where we have revealed several recurrent amino acid motifs—tandem
repeats. In addition, these proteins are characterized by the occurrence of homorepeats when
one amino acid is multiply recurrent. The length of homorepeats can affect not only the
capacity to aggregate but also the toxicity in an aggregated state. Correspondingly, the larger
is the number of repeats, the higher is the probability that the aggregated protein containing
them is associated with the development of the disease. We have established that protein FUS
contains five disordered patterns from the pattern library obtained from the protein data bank:
GSHM, GGGGSGG, GGGGG, GGSGGGGSGGG, and RGGGGSG, which are not located in the
prion-like domain predicted for FUS. For other members of this family, these patterns are not
characteristic and, as known, are less toxic when compared to FUS. When a larger part of the
prion-like domain in protein FUS was removed (100 residues of the 165), it retained its capacity
to aggregate [65], but lost completely the ability to form gel and display toxicity. These results
allow us to suggest that the presence of short repeats in the unstructured prion-like domain
of RNA-binding proteins is required for fast formation of a dynamic cross-beta structure of
SGs [84].
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